acs petroleum research fund
the petroleum research fund is an endowed fund, managed by the american chemical society that supports fundamental research directly related to petroleum or fossil fuels at nonprofit institutions (generally colleges and universities) in the united states and other countries.
acs petroleum research fund (acs prf) grants are intended as seed money, to enable an investigator to initiate a new research direction. the investigator should not have published or received financial support from another funding agency for the proposed research. also, proposals that the acs prf committee feels are a logical extension of an investigator’s previous research may be denied as “not a new direction.”
since the first acs prf grants were approved in 1953, several grant programs have evolved to serve segments of the scientific community, including “new investigator” grants and grants to support researchers in departments that do not award doctoral degrees.
scope of the fund
proposals must be for fundamental research in “the petroleum field,” which is defined in our founding document as “petroleum, natural gas, coal, shale, tar sands and like materials.” fundamental research encompasses the properties of these materials, whereas the petroleum industry undertakes “applied research,” which is outside the scope of acs prf.
the next submission window will be from monday, february 14, 2022 to friday, march 11, 2022 and the submitted proposals will be considered at the october 2022 acs prf committee meeting.
- please contact jill sherman, international research facilitator, if this opportunity is of interest at intl.research@lakeheadu.ca
patient-partnered collaborations for rare neurodegenerative disease
the chan zuckerberg initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. the patient-partnered collaborations for rare neurodegenerative disease rfa aims to advance the understanding of the pathophysiology and mechanistic underpinnings of rare neurodegenerative and neurological disorders.
- please contact jill sherman, international research facilitator, if this opportunity is of interest at intl.research@lakeheadu.ca
patient-partnered collaborations for single-cell analysis of rare inflammatory pediatric disease
the chan zuckerberg initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. the patient-partnered collaborations for single-cell analysis of rare inflammatory pediatric disease rfa aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases that will clarify cellular mechanisms of disease, understand disease heterogeneity, and improve biomarker identification or diagnostics.
- please contact jill sherman, international research facilitator, if this opportunity is of interest at intl.research@lakeheadu.ca
mitacs canadian science policy fellowship
the canadian science policy fellowship (cspf) is now accepting applications from prospective fellows interested in undertaking a year-long policy position with a canadian government host office beginning in september 2022.
eligible applicants must:
- be a canadian citizen or permanent resident*
- hold a phd in any academic discipline at the start of the fellowship
- participate full-time in a 12-month fellowship with the host office
- secure accommodation in the host city, and relocate to their host office as needed
- negotiate a leave of absence from their current employer, as applicable
- meet any additional requirements of their hosts, including (but not limited to) security clearance requirements
the 2022 cohort of fellowships will begin in september 2022. approved fellows receive remuneration from their host offices as well as professional development training and networking events facilitated by mitacs.
responsive call for applications
responsive grants fund initiatives generated by nonprofit community groups to improve access to justice. responsive grants aim to encourage new ideas, approaches, and relationships that can help address emerging needs and connect more people to legal information and supports, especially people who are not currently being reached.
canada – israel 2022-23 collaborative industrial research and development call for proposals
eligibility requirements
to be considered for funding, applicants must form a project consortium and develop a collaborative research and development (r&d) project that meets the following criteria:
canadian applicant
- the canadian applicant must:
- be an incorporated, profit‑oriented small or medium‑sized business in canada
- have 500 or fewer full‑time equivalent employees
- pursue growth and profit by developing and commercializing innovative, technology‑driven new or improved products, services or processes in canada
- have a differentiated and protectable technology that could become competitive in global markets
- have sufficient working capital and resources to undertake a multi‑year r&d collaboration and commercialize the results
- be committed to significant growth through international market expansion
- preference may be given to sme applicants who:
- have a minimum of 15 full‑time equivalent employees
- have commercialized 1 or more products domestically or internationally
- have greater than $500,000 cad in annual revenue
consortium
- the project consortium must include at least:
- 1 incorporated canadian small or medium‑sized enterprise (sme), defined as a for‑profit company with 500 or fewer full‑time equivalent employees
- participation of canadian research institutes/universities, large enterprises and other companies are welcome as additional participants on a self‑funding basis or subcontractors
- 1 eligible israeli r&d‑performing company
- participation of israeli research institutes/universities are welcome as subcontractors
- the parties listed above must be unrelated parties (i.e. no direct, indirect, beneficial or constructive ownership interest between these parties)
- 1 incorporated canadian small or medium‑sized enterprise (sme), defined as a for‑profit company with 500 or fewer full‑time equivalent employees
- the project partners that form the consortium must agree on a plan addressing intellectual property rights and intent to commercialize
working together, the governments of canada and israel aim to foster and support collaborative industrial research and development (r&d) projects with a high potential for commercialization. this call for proposals is open to organizations from canada and israel who wish to form project consortia to perform collaborative projects focused on developing innovative products, processes, or technology‑based services.
- for more information, please click contact jill sherman, international research facilitator at intl.research@lakeheadu.ca
new funding opportunity for canadian drug discovery research
together with the quebec consortium for drug discovery (cqdm), brain canada is pleased to share an upcoming funding opportunity for canadian researchers. cqdm’s quantum leap pharma-led funding program for drug discovery research aims to support innovative translational biopharmaceutical research projects that are at advanced stages of development and that have the potential to improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs.
projects selected as part of the quantum leap program focus on developing cutting-edge technologies with the potential to significantly advance the r&d activities of cqdm’s pharmaceutical members. quantum leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.
brain canada is partnering with the quantum leap pharma-led funding program for drug discovery research on eligible brain related projects.
please note: budget structures can vary depending on each project, please contact cqdm to confirm eligibility before applying.
for more details, please email cqdm at appliquez-apply@cqdm.org and visit their website here.
quebec consortium for drug discovery (cqdm)/brain canada
other : health system impact fellowship
the health system impact fellowship is expected to:
- support impact-oriented career paths and elevate the career readiness of doctoral trainees and post-doctoral fellows studying hspr or related fields by supporting embedded research opportunities within health system and related organizations outside of the traditional university environment and enriched competency development (e.g., leadership, project management);
- expand and enrich the traditional doctoral and post-doctoral training environment by engaging health system and related organizations in preparing a cadre of promising doctoral trainees and post-doctoral fellows for impact-oriented careers in academic and applied health system settings; and
- provide health system and related organizations with direct opportunities to realize and harness the benefits that research-trained individuals can bring to such organizations for rapid learning, improvement and evidence-informed decision-making.